The microenvironment determines the breast cancer cells' phenotype: Organization of MCF7 cells in 3D cultures

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Krause, Silva ^a,b   Maffini, Maricel V ^a   Soto, Ana M ^a   Sonnenschein, Carlos ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1;

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL POLARITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; TUMOR MICROENVIRONMENT; BREAST TUMOR; CELL COMMUNICATION; CELL SHAPE; CHI SQUARE DISTRIBUTION; COCULTURE; CONFOCAL MICROSCOPY; EPITHELIUM CELL; FEMALE; FIBROBLAST; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; TIME; TUMOR CELL LINE;

BASEMENT MEMBRANE; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL POLARITY; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CHI-SQUARE DISTRIBUTION; COCULTURE TECHNIQUES; COLLAGEN TYPE I; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; PHENOTYPE; TIME FACTORS;

EID: 77953066865     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-263     Document Type: Article

References (49)

1. Parmar H, Cunha GR. Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr Relat Cancer 2004, 11:437-458. 10.1677/erc.1.00659, 15369447.
2. Cunha GR, Hom YK. Role of mesenchymal-epithelial interactions in mammary gland development. J Mammary Gland Biol Neoplasia 1996, 1:21-35. 10.1007/BF02096300, 10887478.
3. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000, 60:1254-1260.
4. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004, 117:1495-1502. 10.1242/jcs.01000, 14996910.
5. Sympson CJ, Bissell MJ, Werb Z. Mammary gland tumor formation in trsnsgenic mice overexperssing stromelysin-1. Seminars in Cancer Biology 1995, 6:159-163. 10.1006/scbi.1995.0022, 7495984.
6. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125:681-693. 10.1083/jcb.125.3.681, 2119999, 8175886.
7. Maffini MV, Calabro JM, Soto AM, Sonnenschein C. Stromal regulation of neoplastic development: Age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol 2005, 67:1405-1410.
8. DeCosse JJ, Gossens CL, Kuzma JF, Unsworth BR. Breast cancer: induction of differentiation by embryonic tissue. Science 1973, 181:1057-1058. 10.1126/science.181.4104.1057, 4269415.
9. Coleman WB, Wennerberg AE, Smith GJ, Grisham JW. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Am J Pathol 1993, 142:1373-1382. 1886923, 8494041.
10. McCullough KD, Coleman WB, Ricketts SL, Wilson JW, Smith GJ, Grisham JW. Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc Nat Acad Sci USA 1998, 95:15333-15338. 10.1073/pnas.95.26.15333, 28043, 9860969.
11. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174. 10.1038/nrc745, 11990853.
12. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001, 411:375-379. 10.1038/35077241, 11357145.
13. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1:46-54. 10.1038/35094059, 11900251.
14. Hofmeister V, Schrama D, Becker JC. Anti-cancer therapies targeting the tumor stroma. Cancer Immunol Immunother 2008, 57:1-17. 10.1007/s00262-007-0365-5, 17661033.
15. Oldberg A, Kalamajski S, Salnikov AV, Stuhr L, Morgelin M, Reed RK, Heldin NE, Rubin K. Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc Natl Acad Sci USA 2007, 104:13966-13971. 10.1073/pnas.0702014104, 1955775, 17715296.
16. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, White JG, Keely PJ. Collagen density promotes mammary tumor initiation and progression. BMC Medicine 2008, 6:11. 10.1186/1741-7015-6-11, 2386807, 18442412.
17. Petersen OW, Rønnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Nat Acad Sci USA 1992, 89:9064-9068. 10.1073/pnas.89.19.9064, 50065, 1384042.
18. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007, 1:84-96. 10.1016/j.molonc.2007.02.004, 2391005, 18516279.
19. Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005, 5:675-688. 10.1038/nrc1695, 16148884.
20. Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 2006, 66:1526-1535. 10.1158/0008-5472.CAN-05-3071, 16452209.
21. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, Mooney DJ. Engineering tumors with 3D scaffolds. Nat Methods 2007, 4:855-860. 10.1038/nmeth1085, 17767164.
22. Gorlach A, Herter P, Hentschel H, Frosch PJ, Acker H. Effects of nIFN beta and rIFN gamma on growth and morphology of two human melanoma cell lines: comparison between two- and three-dimensional culture. Int J Cancer 1994, 56:249-254. 10.1002/ijc.2910560218, 8314308.
23. dit Faute MA, Laurent L, Ploton D, Poupon MF, Jardillier JC, Bobichon H. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. Clin Exp Metastasis 2002, 19:161-168. 10.1023/A:1014594825502, 11964080.
24. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 2004, 9:273-285. 10.1177/1087057104265040, 15191644.
25. Dhiman HK, Ray AR, Panda AK. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials 2005, 26:979-986. 10.1016/j.biomaterials.2004.04.012, 15369686.
26. Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK, Labhasetwar V. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 2008, 5:849-862. 10.1021/mp800047v, 18680382.
27. Toh YC, Zhang C, Zhang J, Khong YM, Chang S, Samper VD, van Noort D, Hutmacher DW, Yu H. A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 2007, 7:302-309. 10.1039/b614872g, 17330160.
28. Kashani IR, Barvarestani M, Etesam F, Shokrgozar MA, Abdolvahabi MA, Haddad P, Noori Mokohi MH, Hosseini M. Human preadipocytes inhibit proliferation of MCF-7 breast cancer cell line. Acta Medica Iranica 2006, 44:291-298.
29. Mitsiades C, Sourla A, Doillon C, Lembessis P, Koutsilieris M. Three-dimensional type I collagen co-culture systems for the study of cell-cell interactions and treatment response in bone metastases. J Musculoskelet Neuronal Interact 2000, 1:153-155.
30. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254. 10.1016/j.ccr.2005.08.010, 16169468.
31. Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, Page GP, Thottassery JV, Welch DR, Frost AR. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vivo co-culture. Breast Cancer Res 2005, 7:R46-R59. 10.1186/bcr949, 1064098, 15642169.
32. Krause S, Maffini MV, Soto AM, Sonnenschein C. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Engineering 2008, 14:261-271.
33. Maffini MV, Ortega H, Stoker C, Giardina R, Luque EH, Munoz de Toro MM. Bcl-2 correlates with tumor ploidy and nuclear morphology in early stage prostate carcinoma. Path Res Pract 2001, 197:487-492. 10.1078/0344-0338-00116, 11482579.
34. Kirshner J, Chen CJ, Liu P, Huang J, Shively JE. CEACAM1-4 S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc Nat Acad Sci USA 2003, 100:521-526. 10.1073/pnas.232711199, 141028, 12522268.
35. Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS, Soto AM. Exposure to the xenoestrogen bisphenol-A alters development of the fetal mammary gland. Endocrinology 2007, 148:116-127. 10.1210/en.2006-0561, 2819269, 17023525.
36. Reginato MJ, Mills KR, Becker EB, Lynch DK, Bonni A, Muthuswamy SK, Brugge JS. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol Cell Biol 2005, 25:4591-4601. 10.1128/MCB.25.11.4591-4601.2005, 1140636, 15899862.
37. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 2001, 3:785-792. 10.1038/ncb0901-785, 11533657.
38. Wrobel CN, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J Cell Biol 2004, 165:263-273. 10.1083/jcb.200309102, 2172030, 15117969.
39. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 2002, 94:1494-1503.
40. Howard BA, Gusterson BA. Human breast development. J Mammary Gland Biol Neoplasia 2000, 5:119-137. 10.1023/A:1026487120779, 11149569.
41. Weaver VM, Howlett AR, Langton-Webster B, Petersen OW, Bissell MJ. The development of a functionally relevant cell culture model of progressive human breast cancer. Seminars in Cancer Biology 1995, 6:175-184. 10.1006/scbi.1995.0021, 7495986.
42. Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007, 4:359-365. 10.1038/nmeth1015, 17396127.
43. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo integrin blocking antibody. J Cell Biol 1997, 137:231-245. 10.1083/jcb.137.1.231, 2139858, 9105051.
44. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Nat Acad Sci USA 2008, 105:4329-4334. 10.1073/pnas.0800467105, 2393795, 18334633.
45. Hirschi KK, Xu CE, Tsukamoto T, Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 1996, 7:861-870.
46. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Nat Acad Sci USA 1998, 95:14821-14826. 10.1073/pnas.95.25.14821, 24533, 9843973.
47. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 2002, 62:7102-7109.
48. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 2007, 7:246-255. 10.1038/nrc2108, 17384580.
49. Kasemeier-Kulesa JC, Teddy JM, Postovit LM, Seftor EA, Seftor RE, Hendrix MJ, Kulesa PM. Reprogramming multipotent tumor cells with the embryonic neural crest microenvironment. Dev Dyn 2008, 237:2657-2666. 10.1002/dvdy.21613, 2570047, 18629870.